Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy With or Without Bone Marrow Transplantation in Childhood AML (MRC AML 12)
NCT00003436Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Jul 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of daunorubicin, mitoxantrone in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute promyelocytic leukemia (APL), sponsored by Medical Research Council. Started Jul 1998; status: completed.
02
Drugs
daunorubicinmitoxantrone
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00003436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003436.